Skip to content

CRHD With Persistent Atrial Fibrillation

Long term outcome of patients with symptomatic rheumatic atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091541
Enrollment
500
Registered
2025-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: I088- Other rheumatic multiple valve diseases

Interventions

Intervention1: Direct Current Cardioversion and Pacemaker Implantation with AV Junction ablation: Direct Current Cardioversion and Pacemaker Implantation with AV Junction ablation

Sponsors

Asian health Care Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CRHD patients with Atrial Fibrillation

Exclusion criteria

Exclusion criteria: Non-Rheumatic patients

Design outcomes

Primary

MeasureTime frame
To study improvement in exercise capacity as measured by 6-minute walk test distance (6MWT) following systematic management of symptomatic RHDAF patients.Timepoint: minimum one-year follow-up

Secondary

MeasureTime frame
1. To Study change in functional class over 1year follow-up. 2. To study improvement in cardiac biomarker NT-proBNP over 1year follow-up. 3. To study number of heart failure related hospital admissions over 1year follow-up. 4. To study improvement in left ventricular ejection fraction (modified Simpson’s method)/pulmonary artery systolic pressure (PASP)/tricuspid regurgitation/Mitral regurgitation/left atrial volume and dimension over 1year follow-up. Timepoint: over a period of 1 year follow up

Countries

India

Contacts

Public ContactDaljeet kaur saggu

AIG Hospitals

drdaljeetsaggu@gmail.com918978428938

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026